Phase I-II

LMC Manna, IACT Health join in integrated research network

23-Nov-2021 By Jenni Spinner

The alliance is aimed at expanding service to pharmaceutical firms and other partners, and advancing treatment options for patients across North America.

Reify Health launches tool to gauge clinical trial diversity

22-Nov-2021 By Jenni Spinner

The StudyTeam Diversity Reporting feature is intended to aid sites and sponsors measure their efforts to reach patients from underrepresented communities.

Tech Innovations: November 2021

18-Nov-2021 By Jenni Spinner

This month’s launches, expanded facilities, partnerships, and other news includes items from Veeva, Hovione, Florence, Medidata, and other notable firms.

More sites and sponsors betting on decentralized format: Science 37

17-Nov-2021 By Jenni Spinner

According to data released by the company, the majority of study professionals plan to run agile or hybrid trials over the course of the next 12 months.

Gene-edited cell replacement therapy for diabetes set to enter the clinic

16-Nov-2021 By Rachel Arthur

CRISPR Therapeutics and ViaCyte, Inc. have received the green light from Health Canada for their Clinical Trial Application for VCTX210: an allogeneic, gene-edited, immune-evasive, stem cell-derived therapy for the treatment of type 1 diabetes (T1D)....

TFF completes dosing in Phase Ib clinical study for asthma drug

15-Nov-2021 By Jenni Spinner

The firm is investigating viability of voriconazole inhalation powder, intended to treat and prevent invasive pulmonary aspergillosis in asthma patients.

Biohaven wraps patient enrollment for ALS clinical trial arm

15-Nov-2021 By Jenni Spinner

The pharma company has completed enrollment of amyotrophic lateral sclerosis patients in its study investigating drugs like verdiperstat, an oral treatment.

Sanofi, Be the Match, and DiMe to weigh in on patient centricity

11-Nov-2021 By Jenni Spinner

During our November 17 webinar Patient-centric solutions, a group of professionals representing a range of perspectives will share ideas and innovations.

Clinical Ink snaps up digital CNS research technology firm

08-Nov-2021 By Jenni Spinner

The decentralized tech specialist has acquired Digital Artefacts, a research tech firm focused on cognitive, behavioral, and physiological data capture.

Industry veteran commits to improved patient solutions at CTMA

08-Nov-2021 By Jenni Spinner

After 30 years’ experience, including stints advising top pharma firms, the expert has joined a firm offering tech aimed at elevating patient ID and enrollment.

People on the Move: November 2021

04-Nov-2021 By Jenni Spinner

This month’s announcements of programs, names, appointments, hires, and other happenings includes items from Emmes, Science 37, Cerner and other companies.

Study coordinator pleads guilty to trial data falsification

01-Nov-2021 By Jenni Spinner

A former employee of Tellus Clinical Research in Miami has admitted to charges related to a conspiracy to falsify data on a list of clinical drug trials.

Gilead, Merck launch Phase II trial evaluating oral regimen for HIV-1 treatment

01-Nov-2021 By Jenni Spinner

The trial will evaluate a weekly regimen of islatravir and lnecapavir in HIV patients who are virologically suppressed while on antiretroviral therapies.

Digital transformation of clinical research accelerating rapidly: Veeva Systems

01-Nov-2021 By Jenni Spinner

The cloud software firm’s Digital Clinical Trials Survey Report reveals that the industry is adapting to challenges caused by COVID-19 and other factors.

Increased representation benefits cancer clinical trials: Science 37

28-Oct-2021 By Jenni Spinner

An expert from the decentralized study solutions company shares perspectives on the importance of inclusivity and solutions that could improve representation.

How can clinical research be truly patient centric?

28-Oct-2021 By Jenni Spinner

During OSP’s November 17 online event, a group of experts will offer insights, advice, and examples of solutions that put patients at the center of studies.

Survey: pandemic viewed as catalyst for positive change in trials

26-Oct-2021 By Jenni Spinner

According to a recent survey from Oracle Health Sciences, 97% of trial professionals say newly adopted approaches will stay in use as we move beyond COVID-19.

Speaking the language of diverse patient populations is vital: TransPerfect

25-Oct-2021 By Jenni Spinner

A leader from the language and tech solutions firm explains how multilingual support can improve patient recruitment and other aspects of clinical trials.

Global Genes partners to elevate equity for rare disease patients

25-Oct-2021 By Jenni Spinner

The advocacy group is joining with the Rare Disease Diversity Coalition on an initiative to identify and overcome challenges faced by minority patients.

Tech Innovations: October 2021

21-Oct-2021 By Jenni Spinner

This month’s list of partnerships, manufacturing facilities, new technologies and other items includes AstraZeneca, Charles River, Veeva, and other firms.

Centralizing patient recruitment stands to elevate outcomes: Trialbee

21-Oct-2021 By Jenni Spinner

With the launch of its Trialbee Honey technology, the company aims to bring together recruitment information from different sources for sweeter results.

UCI, Syntropy join forces on research/care data project

19-Oct-2021 By Jenni Spinner

The University of California at Irvine and the data firm will work on solutions that help integrate health data for both clinical trials and patient care.

‘Digital transformation’ requires enterprise-wide change: Rockwell Automation

19-Oct-2021 By Jenni Spinner

To fully reap the benefits of tech advances, a company leader advises, a life-sciences firm must embrace change and connection throughout the operation.

BBK Worldwide clinical travel program hits 20,000 trips

19-Oct-2021 By Jenni Spinner

RSG Arrive is intended to increase clinical trial participation by offering ground transport, plane rides, hotels, visa procurement, and other services.

Survey seeks to chart adoption of decentralized trials, future plans

18-Oct-2021 By Jenni Spinner

A study from Climedo Health aims at revealing the growing influence the decentralized format is enjoying across the industry and what might lie ahead.

COVID-19 lessons can apply to hepatitis treatments: Phesi

18-Oct-2021 By Jenni Spinner

According to the firm, infectious-disease research advancements could be applied to discovering treatments for millions of hepatitis patients globally.

‘Progress does not happen overnight’: Sanofi on evolution of medicine

14-Oct-2021 By Jenni Spinner

A leader from the pharmaceutical firm talks about some of the most impactful technologies and shares a number of notable advancements made by the company.

Increasing trial diversity ‘top of mind’ for Lilly Oncology

12-Oct-2021 By Jenni Spinner

A leader from the division of Eli Lilly explains the importance of driving greater trial inclusivity, and why collaboration is vital in making progress.

Mastering data management can lead to improved outcomes: CitiusTech

11-Oct-2021 By Jenni Spinner

According to two leaders from the healthcare tech firm, improving the way healthcare data is collected, stored, and used can contribute to improved care.

Medable launches Site Network Council to elevate decentralized trials

11-Oct-2021 By Jenni Spinner

The patient-centric platform firm is gathering representatives from different corners of the industry to work on solutions to drive progress and innovation.

Metrics make a difference in clinical research advancement: Advarra

07-Oct-2021 By Jenni Spinner

An expert from the IRB and study solutions firm explains how advanced analytics can lead to several benefits, including shortened trial startup timelines.

People on the Move: October 2021

07-Oct-2021 By Jenni Spinner

This month’s news on appointments, expansions, acquisitions and other events includes Nanoform, Elligo Health Research, Curavit, and other organizations.

Informatics useful in advancing personalized medicine: Washington University

05-Oct-2021 By Jenni Spinner

A representative from the school explains how tools like artificial intelligence and natural language processing can help elevate personalized medicine.

Making the most of trial data can benefit patients: Parexel

05-Oct-2021 By Jenni Spinner

An expert from the CRO explains the evolution of data technologies put to use in clinical studies and offers advice on how to best make them work in trials.

Rise of DCTs calls for elevated patient recruitment strategy: SubjectWell

04-Oct-2021 By Jenni Spinner

According to the CEO of patient recruitment specialist SubjectWell, keeping up with the specialized needs of virtual studies calls for innovative thinking.

Patients want to see more health industry collaboration: survey

30-Sep-2021 By Jenni Spinner

A study by Charles River finds patients believe the overall quality of healthcare would increase if stakeholders across the life sciences collaborated more.

Mobile technology facilitates decentralized skin and wound trials

30-Sep-2021 By Jenni Spinner

A leader from Swift Medical describes the company’s skin and wound management technology, and how their tech empowers patient capture of vital information.

Merck to acquire Acceleron Pharma, strengthening cardiovascular pipeline

30-Sep-2021 By Rachel Arthur

Merck (MSD outside the US and Canada) will acquire Acceleron in a deal worth around $11.5bn.

COVID-19 treatment candidate headed to clinical trial in 2022

28-Sep-2021 By Jenni Spinner

Q BioMed reports it expects candidate MAN-19, intended to treat COVID-19-related Acute Respiratory Distress Syndrome, to enter trials early next year.

Eli Lilly partners with Care Access to increase trial diversity

28-Sep-2021 By Jenni Spinner

The pharmaceutical firm has tapped the decentralized research organization in order to help elevate the inclusivity of its oncology trials at all levels.

CROs facing formidable challenges in clinical research: survey

28-Sep-2021 By Jenni Spinner

Conducted by patient services specialist Greenphire, the survey checks in with contract research organizations and shows how they are approaching obstacles.

Real-world data use in trials can yield real benefits: Firma

27-Sep-2021 By Jenni Spinner

A leader from Firma Clinical Research advises that while using RWD can be daunting, putting the data to use can lead to a number of notable advantages.

Pfizer kicks off trial for COVID-19 oral antiviral candidate

27-Sep-2021 By Jenni Spinner

The protease inhibitor PF-07321332 (co-administered with ritonavir) is designed for patients exposed to (or showing the first signs of) the COVID-19 virus.

Remarque lands patent for risk-based quality management platform

27-Sep-2021 By Jenni Spinner

The technology is designed to enable connection to any source data system, enabling connectivity in identifying, monitoring, and managing trial risks.

Update on FDA COVID approvals, actions, and advice

24-Sep-2021 By Jenni Spinner

As COVID-19 and its variants continue their attack, the agency maintains its position of overseer and giver of advice on various treatments and vaccines.

Salarius Pharmaceuticals forms research partnership with Fox Chase Cancer Center

24-Sep-2021 By Jenni Spinner

The cancer-centric pharma firm will collaborate with the Philadelphia-based cancer center to pinpoint new indications and biomarkers for its drug candidate.

Signant clinical supply chain software offers end-to-end visibility

22-Sep-2021 By Jenni Spinner

SmartSignals Supplies is designed to help trial teams get a handle on clinical trial supply chain management to avoid delays, waste, and cost overruns.

Life-science logistics specialist opens Los Angeles location

22-Sep-2021 By Jenni Spinner

Biocair has expanded its pharmaceutical and clinical trial logistics operations with new location in California, near Los Angeles International Airport.

Connections, collaboration key to executing global trials: ICON

22-Sep-2021 By Jenni Spinner

A logistics leader from the CRO offers advice on navigating borders, cultures, regulatory issues and other important considerations on worldwide studies.

Decentralized trial logistics requires thoughtful strategy: Marken

22-Sep-2021 By Jenni Spinner

A leader from the global clinical research logistics company shares how to weigh the complex aspects of a decentralized trial and craft intelligent strategy.